Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03612466
What this trial is testing

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Who this might be right for
OsteosarcomaBone Metastases
Albert Einstein College of Medicine
Not applicableStudy completedNCT03800121
What this trial is testing

Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC)

Who this might be right for
Sarcoma
Centre Georges Francois Leclerc 34
Not applicableLooking for participantsNCT04690374
What this trial is testing

Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor

Who this might be right for
Desmoplastic Small Round Cell Tumor
Memorial Sloan Kettering Cancer Center 250
Not applicableStudy completedNCT07093320
What this trial is testing

Saving Limbs After Cancer: Blood Vessel and Soft Tissue Reconstruction Following Sarcoma Surgery in the Legs

Who this might be right for
Soft Tissue Sarcoma (STS)
European Georges Pompidou Hospital 16
Early research (Phase 1)Study completedNCT00580320
What this trial is testing

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Who this might be right for
MelanomaSoft Tissue SarcomaParathyroid Carcinoma+2 more
Virginia Commonwealth University 17
Not applicableStudy completedNCT04224948
What this trial is testing

The PET- Retroperitoneal Sarcoma Study

Who this might be right for
Retroperitoneal Sarcoma
University Health Network, Toronto 18
Not applicableStudy completedNCT03977818
What this trial is testing

Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa

Who this might be right for
SarcomaMetastasesChemotherapy
Institut Bergonié 2,165
Testing effectiveness (Phase 2)Ended earlyNCT01048723
What this trial is testing

Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas

Who this might be right for
Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Study completedNCT00324779
What this trial is testing

Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaLymphoma
University Hospital Erlangen 79
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Early research (Phase 1)Study completedNCT01518413
What this trial is testing

Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors

Who this might be right for
Rhabdomyosarcoma and Other Soft Tissue SarcomasEwing's Sarcoma Family of TumorsOsteosarcoma+2 more
HMeany 17
Not applicableStudy completedNCT01846520
What this trial is testing

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Who this might be right for
Healthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more
City of Hope Medical Center 200
Early research (Phase 1)Looking for participantsNCT05492682
What this trial is testing

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Who this might be right for
Melanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more
Valo Therapeutics Oy 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04417062
What this trial is testing

Olaparib With Ceralasertib in Recurrent Osteosarcoma

Who this might be right for
OsteosarcomaOsteosarcoma Recurrent
Dana-Farber Cancer Institute 49
Testing effectiveness (Phase 2)Study completedNCT00503295
What this trial is testing

Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung

Who this might be right for
OsteosarcomaEwing Sarcoma Family TumorsMalignant Fibrous Histiocytoma+3 more
Oncolytics Biotech 53
Testing effectiveness (Phase 2)Study completedNCT00516295
What this trial is testing

Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma

Who this might be right for
Ewing Sarcoma of BoneExtraosseous Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor+1 more
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07547592
What this trial is testing

Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma

Who this might be right for
Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site
Yonsei University 92
Testing effectiveness (Phase 2)Study completedNCT00864032
What this trial is testing

Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall

Who this might be right for
Soft Tissue Sarcoma
University of California, Davis 8
Testing effectiveness (Phase 2)Study completedNCT03798106
What this trial is testing

Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Yonsei University 46
Early research (Phase 1)WithdrawnNCT05799612
What this trial is testing

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Who this might be right for
Angiosarcoma
M.D. Anderson Cancer Center
Next Page